Survival Trends and Prognostic Modeling in ALK‐Positive Anaplastic Large Cell Lymphoma: A Population‐Based Study in the Brentuximab Vedotin Era
ABSTRACT Background ALK‐positive anaplastic large cell lymphoma (ALK+ ALCL) is a rare subtype of peripheral T‐cell lymphoma with traditionally favorable prognosis. The introduction of brentuximab vedotin (BV) has significantly impacted treatment outcomes, but the long‐term survival trends and predic...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wiley
2026-03-01
|
| Edice: | Cancer Medicine |
| Témata: | |
| On-line přístup: | https://doi.org/10.1002/cam4.71695 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|